info@news-matic.com

details

Kalohexis Appoints Garry Menzel, Ph.D., to Board of Directors

Dr. Menzel brings over 30 years of global healthcare executive leadership with broad experience in building successful companies NORTHBROOK, Ill., Sept. 1, 2026 /PRNewswire/ -- Kalohexis, Inc., a clinical-stage biotechnology company harnessing the melanocortin system to shape the next era...

ADVERTISEMENT

Cookie Consent + Tracking